Toxic Epidermal Necrolysis with Levofloxacin;Serotonin Syndrome Associated with Linezolid;Severe Hypokalemia Seen with Dicloxacillin Therapy;Terfinabine Hepatotoxicity
Restricted accessResearch articleFirst published online September, 2002
Toxic Epidermal Necrolysis with Levofloxacin;Serotonin Syndrome Associated with Linezolid;Severe Hypokalemia Seen with Dicloxacillin Therapy;Terfinabine Hepatotoxicity
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
Diwood-LettieriS., ReillyK.J., HaithL.R.Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.Pharmacotherapy.2002; 22: 789–93.
2.
WigenC.L., GoetzM.B.Serotonin syndrome and linezolid.Clin Infect Dis.2002; 34: 1651–2.
3.
JohnsonD.W., KayT.D., HawleyC.M.Severe hypokalaemia secondary to dicloxacillin.Inter Med J.2002; 32: 357–8.
4.
WysowskiD.K., HonigS.F., BeitzJ.Uterine sarcoma associated with tamoxifen use [letter].N Eng J Med.2002; 346: 1832–3.
5.
MackeyA.C., ShafferD., PrizantR.Seizure associated with the use of Visicol for colonoscopy [letter].N Eng J Med.2002; 346: 2095.
6.
AnaniaF.A., RabinL.Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis [letter].Am J Med.2002; 112741–42.
